Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Text Messaging and NRT for Smoking Cessation
NCT03174158Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by Massachusetts General Hospital. Started Nov 2017; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03174158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03174158.